Hamamatsu and Axiogenesis respective leaders in imaging / high throughput screening and stem cell derived models for research and development are happy to be organising the following seminar.
The Key note speaker Dr Thierry Calmelsof Bioprojet Biotech France will present: "Cor.4U human iPSC-derived cardiomyocytes-based calcium assay to predict GPCR ligands cardiac safety profile on FDSS/μCell platform"
15.00 Arrival and Welcome from the Chair
Session 1: Overview of iPS solution & imaging assay
Axiogenesis stem cell derived models, Axiogenesis AG, Cologne, Germany, www.axiogenesis.com
hiPSC-derived cardiomyocytes, neurons and muscle cells
Overview of Hamamatsu solution for iPS assay, Hamamatsu Photonics, www.hamamatsu.co.uk
Drug profiling with voltage and calcium-sensitive fluorescent probes in human iPSC-derived cardiomyocytes
Thierry Calmels, Bioprojet Biotech, Rennes, France
Cor.4U human iPSC-derived cardiomyocytes-based calcium assay to predict GPCR ligands cardiac safety profile on FDSS/μCell platform
Session 2: Live demo FDSS/μCell (Hamamatsu) & Cor4U iPSC derived cardiomyocytes
Ruediger Bader firstname.lastname@example.org
Address for information:
Clinical Engineering, University of Liverpool
The Duncan Building Daulby Street Liverpool L69 3GA U.K.